$FOXO Technologies(FOXO.US$
在周一的盘前交易中,FOXO Technologies(美国证券交易所股票代码:FOXO)股价上涨了102.9%,至0.27美元。他们已发行股票的市值为1,330万美元。
在周一的盘前交易中,FOXO Technologies(美国证券交易所股票代码:FOXO)股价上涨了102.9%,至0.27美元。他们已发行股票的市值为1,330万美元。
已翻译
$Beneficient(BENF.US$
Beneficient Entered Into $250M Standby Equity Purchase Agreement With YA II PN; Pursuant To SEPA
Beneficient Entered Into $250M Standby Equity Purchase Agreement With YA II PN; Pursuant To SEPA
$Minerva Neurosciences(NERV.US$
just wait for another wave of high $10.40
just wait for another wave of high $10.40
2
4
$GEN Restaurant Group(GENK.US$
阅读:Cava Group 首席财务官相信连锁餐厅将实现盈利,但她不会透露何时盈利
第二季度IPO市场收盘的势头比最初更大,因为目前有六次IPO计划在6月的最后一周进行,其中四次预计将获得超过1亿美元的收入。
阅读:Cava Group 首席财务官相信连锁餐厅将实现盈利,但她不会透露何时盈利
第二季度IPO市场收盘的势头比最初更大,因为目前有六次IPO计划在6月的最后一周进行,其中四次预计将获得超过1亿美元的收入。
已翻译
1
$Minerva Neurosciences(NERV.US$
(NASDAQ:NERV) are shooting higher after the company bagged a $20 million investment from Boehringer Ingelheim and Federated Hermes Kaufmann Funds via private placement of its shares, priced at a premium to the current levels.
Minerva has agreed to sell an aggregate of 1.43 million shares of its common stock at a purchase price of $10 per share and pre-funded warrants to purchase an aggregate of 575,575 shares at a purchase price of $9.99 per pre-funded warrant.
(NASDAQ:NERV) are shooting higher after the company bagged a $20 million investment from Boehringer Ingelheim and Federated Hermes Kaufmann Funds via private placement of its shares, priced at a premium to the current levels.
Minerva has agreed to sell an aggregate of 1.43 million shares of its common stock at a purchase price of $10 per share and pre-funded warrants to purchase an aggregate of 575,575 shares at a purchase price of $9.99 per pre-funded warrant.
2